These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Editorial explanation for Clinical practice guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in treatment of rheumatoid arthritis].
    Author: Na L, Quan J, Wei L, Jian L, Qing-Chun H, Kuan-Yu WU, Sheng-Hao TU, Zu-Shan Z, Wei-Heng C, Xiao-Xia LI, Yan-Qiong Z, Tai-Xian LI.
    Journal: Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4154-4157. PubMed ID: 33164400.
    Abstract:
    Clinical practice guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the treatment of rheumatoid arthritis(T/CACM 1337-2020) was approved on June, 2020 by the Standardization Office of Chinese Association of Chinese Medicine. Our group developed this guideline for the clinical application of Tripterygium Glycosides/Tripterygium wilfordii Tablets according to the manual for the clinical experts consensus of Chinese patent medicine from January, 2018, when this project was approved by Chinese Association of Chinese Medicine. In this article, the detailed information on our compilation process was provided, in order to facilitate the understanding and the application of the guideline, as well as provide reference for the development of clinical practice guideline for other Chinese patent medicine.
    [Abstract] [Full Text] [Related] [New Search]